Messenger RNA Technology Could Be Used to Develop Infectious Disease Therapeutics
Army scientists and industry partners were among the first to demonstrate that messenger RNA (mRNA)–the technology recently used in COVID-19 vaccines and others–could also be used to develop treatments for infectious diseases.
Austin, Texas – Sgt. Ibrahim Toure had planned and waited for years to make it to the United States, a place he thought of as offering greater freedom and possibilities.
Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process
Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection in humans.
Antibody Shows Promise for Developing Hantavirus Treatment
An international research team discovered the first human antibody to effectively neutralize two types of hantaviruses in animal models, according to a study published online Mar. 16 in Science Translational Medicine.
USAMRIID Scientist Wins AMSUS Research and Development Award
Xiankun (Kevin) Zeng, Ph.D., a molecular biologist and principal investigator at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), is the recipient of the 2021-2022 Research and Development Award presented by AMSUS, the Society of Federal Health Professionals.
Study Reveals Ebola Virus Can Hide in Brain, Persist Even After Treatment
In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease–even long after treatment with monoclonal antibodies.
Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection
Scientists have demonstrated that modifying an enzyme produced by the bacterium that causes anthrax can protect mice from infection with the deadly disease.
To provide leading edge medical capabilities to deter and defend against current and emerging biological threat agents.
— Vision —
To advance medical biological defense to protect our military and the nation.
Since 1969, USAMRIID has served as the Department of Defense's (DoD) lead laboratory for medical biological defense research. While our core mission is to protect the warfighter from biological threats, we also investigate disease outbreaks and threats to public health. Research conducted at USAMRIID leads to medical solutions—therapeutics, vaccines, diagnostics, and information—that benefit both military personnel and civilians. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Development Command.
This Web site provides an introduction to the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and contains official information.
It is intended for interested members of the public, news media and Army Medical Department beneficiaries.
Please address questions and concerns about this website to the USAMRIID Webmaster via email.